195 related articles for article (PubMed ID: 38396844)
21. Overexpression of lncRNA HOXA-AS2 promotes the progression of oral squamous cell carcinoma by mediating SNX5 expression.
Li Z
BMC Mol Cell Biol; 2022 Dec; 23(1):59. PubMed ID: 36528556
[TBL] [Abstract][Full Text] [Related]
22. Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.
Gao W; Zhang C; Li W; Li H; Sang J; Zhao Q; Bo Y; Luo H; Zheng X; Lu Y; Shi Y; Yang D; Zhang R; Li Z; Cui J; Zhang Y; Niu M; Li J; Wu Z; Guo H; Xiang C; Wang J; Hou J; Zhang L; Thorne RF; Cui Y; Wu Y; Wen S; Wang B
Mol Ther; 2019 Feb; 27(2):365-379. PubMed ID: 30341010
[TBL] [Abstract][Full Text] [Related]
23. Decreased expression of mitochondrial miR-5787 contributes to chemoresistance by reprogramming glucose metabolism and inhibiting MT-CO3 translation.
Chen W; Wang P; Lu Y; Jin T; Lei X; Liu M; Zhuang P; Liao J; Lin Z; Li B; Peng Y; Pan G; Lv X; Zhang H; Ou Z; Xie S; Lin X; Sun S; Ferrone S; Tannous BA; Ruan Y; Li J; Fan S
Theranostics; 2019; 9(20):5739-5754. PubMed ID: 31534516
[TBL] [Abstract][Full Text] [Related]
24. lncRNA HOXA11-AS maintains the stemness of oral squamous cell carcinoma stem cells and reduces the radiosensitivity by targeting miR-518a-3p/PDK1.
Li B; Lv Y; Zhang C; Xiang C
J Oral Pathol Med; 2023 Mar; 52(3):216-225. PubMed ID: 36661031
[TBL] [Abstract][Full Text] [Related]
25. Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells.
Hummel R; Watson DI; Smith C; Kist J; Michael MZ; Haier J; Hussey DJ
J Gastrointest Surg; 2011 Mar; 15(3):429-38. PubMed ID: 21246413
[TBL] [Abstract][Full Text] [Related]
26. Complex Epigenetic Regulation of Chemotherapy Resistance and Biohlogy in Esophageal Squamous Cell Carcinoma via MicroRNAs.
Lindner K; Eichelmann AK; Matuszcak C; Hussey DJ; Haier J; Hummel R
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29414899
[TBL] [Abstract][Full Text] [Related]
27. [Circular RNA circHIPK3 acts as the sponge of microRNA-124 to promote human oral squamous cell carcinoma cells proliferation].
Wang J; Zhao SY; Ouyang SS; Huang ZK; Luo Q; Liao L
Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Aug; 53(8):546-551. PubMed ID: 30078268
[No Abstract] [Full Text] [Related]
28. Up-regulation of TNF-alpha/NFkB/SIRT1 axis drives aggressiveness and cancer stem cells accumulation in chemoresistant oral squamous cell carcinoma.
de Castro LR; de Oliveira LD; Milan TM; Eskenazi APE; Bighetti-Trevisan RL; de Almeida OGG; Amorim MLM; Squarize CH; Castilho RM; de Almeida LO
J Cell Physiol; 2024 Feb; 239(2):e31164. PubMed ID: 38149816
[TBL] [Abstract][Full Text] [Related]
29. Role of Host miRNA Hsa-miR-139-3p in HPV-16-Induced Carcinomas.
Sannigrahi MK; Sharma R; Singh V; Panda NK; Rattan V; Khullar M
Clin Cancer Res; 2017 Jul; 23(14):3884-3895. PubMed ID: 28143871
[No Abstract] [Full Text] [Related]
30. Regulation of transforming growth factor-beta1 by circANKS1B/miR-515-5p affects the metastatic potential and cisplatin resistance in oral squamous cell carcinoma.
Yan J; Xu H
Bioengineered; 2021 Dec; 12(2):12420-12430. PubMed ID: 34781814
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells.
Zheng H; Wang JJ; Yang XR; Yu YL
World J Gastroenterol; 2020 Feb; 26(5):499-513. PubMed ID: 32089626
[TBL] [Abstract][Full Text] [Related]
32. Exploring miR-155-5p and miR-1246 as Diagnostic and Prognostic Markers in Oral Squamous cell carcinoma.
Maheswari R; Urs AB; Kumar P; Koner BC; Guru SA; Rawat G
Mol Biol Rep; 2024 Feb; 51(1):341. PubMed ID: 38400867
[TBL] [Abstract][Full Text] [Related]
33. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
Bourguignon LY; Wong G; Earle C; Chen L
J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
[TBL] [Abstract][Full Text] [Related]
34. METTL3/14 and IL-17 signaling contribute to CEBPA-DT enhanced oral cancer cisplatin resistance.
Qiao X; Zhu L; Song R; Shang C; Guo Y
Oral Dis; 2023 Apr; 29(3):942-956. PubMed ID: 34807506
[TBL] [Abstract][Full Text] [Related]
35. A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway.
Huang WC; Jang TH; Tung SL; Yen TC; Chan SH; Wang LH
J Exp Clin Cancer Res; 2019 Feb; 38(1):89. PubMed ID: 30782177
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-624-mediated ARRDC3/YAP/HIF1α axis enhances esophageal squamous cell carcinoma cell resistance to cisplatin and paclitaxel.
Yan J; Shi L; Lin S; Li Y
Bioengineered; 2021 Dec; 12(1):5334-5347. PubMed ID: 34415232
[TBL] [Abstract][Full Text] [Related]
37. [Insight into the role of IGF2BP1 in drug resistant mechanism of oral squamous cell carcinoma].
Xie F; Qin X; Tong T; Jiang YY; Zhang JJ
Shanghai Kou Qiang Yi Xue; 2021 Oct; 30(5):456-461. PubMed ID: 34888594
[TBL] [Abstract][Full Text] [Related]
38. Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma.
Nohata N; Hanazawa T; Kinoshita T; Inamine A; Kikkawa N; Itesako T; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
Br J Cancer; 2013 Apr; 108(8):1648-58. PubMed ID: 23558898
[TBL] [Abstract][Full Text] [Related]
39. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA profiling of cisplatin-resistant oral squamous cell carcinoma cell lines enriched with cancer-stem-cell-like and epithelial-mesenchymal transition-type features.
Ghosh RD; Ghuwalewala S; Das P; Mandloi S; Alam SK; Chakraborty J; Sarkar S; Chakrabarti S; Panda CK; Roychoudhury S
Sci Rep; 2016 Apr; 6():23932. PubMed ID: 27045798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
